Related Experiment Video
Updated: Sep 13, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal Vaccine
1Stony Brook University School of Nursing, 101 Nicolls Road, Stony Brook, NY 11794-8240, USA.
Insights
Pneumococcal conjugate vaccines significantly reduce childhood and adult pneumonia. Updates in vaccine serotypes and administration schedules improve disease prevention, addressing disparities.
Area of Science:
- Bacteriology
- Immunology
- Public Health
Background:
- Pneumococci are a leading cause of bacterial pneumonia in children under 5 and adults.
- Community-acquired pneumonia in adults is frequently caused by pneumococci.
- Pneumococcal conjugate vaccines have dramatically decreased pneumococcal disease incidence.
Purpose of the Study:
- To review the impact of pneumococcal conjugate vaccines on disease incidence.
- To discuss the evolution of pneumococcal vaccines, including expanded serotype coverage.
- To examine changes in vaccine administration schedules based on age and health status.
- To address the development, implementation, and racial disparities associated with pneumococcal vaccines.
Main Methods:
- Literature review of pneumococcal disease epidemiology.
- Analysis of vaccine efficacy data for conjugate pneumococcal vaccines.
- Examination of public health policy regarding vaccination schedules.
- Discussion of research on racial disparities in pneumococcal disease and vaccination.
Main Results:
- Conjugate pneumococcal vaccines have proven highly effective in reducing disease burden.
- Vaccine formulations have been updated to cover a broader range of pneumococcal serotypes.
- Vaccination schedules are dynamic, adapting to age and individual risk factors.
- Racial disparities persist in pneumococcal disease incidence and vaccine uptake.
Conclusions:
- Pneumococcal conjugate vaccines are critical tools for preventing pneumonia and invasive disease.
- Ongoing vaccine development and schedule optimization are essential.
- Addressing racial disparities is crucial for equitable disease prevention.
Abstract:
Pneumococci are the most common bacterial cause of childhood pneumonia, especially in children aged younger than 5 years. In adults, pneumococci account for 10% to 30% of adult community-acquired pneumonia. The conjugate pneumococcal vaccines have been shown to have a remarkable effect, reducing the incidence of all types of pneumococcal diseases. Overtime the vaccines have been updated to include protection against more serotypes. Schedules for administration have also changed based on age and pre-existing conditions. Development and implementation of pneumococcal vaccines and racial disparities are discussed.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:27Pneumothorax-II
Clinical Manifestations: